新闻
2024-01-31
MaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for Cancers
细胞疗法引进/卖出免疫疗法快速通道孤儿药
2024-01-30
2024-01-30
Oxford Biomedica completes acquisition of ABL Europe
并购基因疗法
2024-01-29
抗体药物偶联物
2024-01-29
Orion Corporation and Newel Health enter into licensing agreement for a digital therapeutic (DTx) ODD-403 (“Rohkea”) in pain
引进/卖出并购
2024-01-25
MaxCyte Signs Strategic Platform License with Imugene to Advance their Cancer Immunotherapy Programs
免疫疗法引进/卖出细胞疗法
2024-01-25
引进/卖出抗体药物偶联物核酸药物基因疗法
2024-01-25
蛋白降解靶向嵌合体引进/卖出并购
2024-01-24
AC Immune to Regain Global Rights to Crenezumab and Semorinemab
免疫疗法临床结果引进/卖出
2024-01-23
抗体药物偶联物上市批准引进/卖出生物类似药医药出海